Elanco Animal Health Incorporated (ELAN)
NYSE
Closed
Oct 8, 2026
Day's Range
22.0052 wk Range
19.40Overview - ELAN - Elanco Animal Health Incorporated
Key Statistics
Valuation
Enterprise Value
14.76B
P/E (Trailing)
‪377.14‬
P/E (Forward)
‪17.23‬
PEG Ratio
‪0.83‬
Price / Sales (TTM)
‪2.20‬
Price / Book
‪1.67‬
EV / EBITDA
‪14.66‬
Profitability
Gross Margin
‪58.33%‬
Profit Margin
‪-3.96%‬
Operating Margin
‪8.62%‬
Return on Assets
‪1.55%‬
Return on Equity
‪-2.97%‬
Ownership
Shares Outstanding
499.54M
Float
495.40M
Short % of Shares Outstanding
‪10.12%‬
Held by Insiders
‪1.20%‬
Held by Institutions
‪115.27%‬
Price stats
Beta
‪1.67‬
50-Day Avg
‪23.81‬
200-Day Avg
‪23.80‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
16 analysts
Average price target
‪$ 31.21‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ELAN - Elanco Animal Health Incorporated
Peers - ELAN - Elanco Animal Health Incorporated
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NYSE.
Profile Summary - ELAN - Elanco Animal Health Incorporated
About
Elanco Animal Health Incorporated is an animal health company focused on developing, manufacturing, and marketing products for pets and farm animals. Its portfolio includes treatments and preventive solutions for parasitic control, dermatology, pain management, vaccines, and other therapeutic areas used in companion…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
